Home

Elevation Oncology, Inc. - Common stock (ELEV)

0.2780
-0.1998 (-41.82%)

Elevation Oncology Inc is a biopharmaceutical company focused on developing targeted therapies for patients with genomically defined cancers

The company is dedicated to understanding the unique genetic drivers of these diseases and aims to create innovative treatment options that address unmet medical needs. By leveraging its expertise in precision medicine and oncology, Elevation Oncology works to advance its clinical pipeline, providing hope to patients with rare and challenging cancer types through personalized and effective therapeutic strategies.

SummaryNewsPress ReleasesChartHistoricalFAQ
Here are the top movers in Thursday's session.chartmill.com
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via Chartmill · March 20, 2025
Top movers in Thursday's sessionchartmill.com
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · March 20, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · March 20, 2025
Recap: Elevation Oncology Q4 Earningsbenzinga.com
Via Benzinga · March 6, 2024
Which stocks are gapping on Thursday?chartmill.com
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · March 20, 2025
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increasebenzinga.com
Via Benzinga · March 20, 2025
Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%benzinga.com
Elevation Oncology ends EO-3021 development after Phase 1 results, shifts focus to EO-1022, and plans a major workforce reduction to extend funding.
Via Benzinga · March 20, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 20, 2025
Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Resultsbenzinga.com
Via Benzinga · March 20, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · March 13, 2025
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praisebenzinga.com
Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021 showing promising Phase 1 results and a $6.6 billion TAM in gastric and pancreatic cancers.
Via Benzinga · January 3, 2025
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Fridaybenzinga.com
Via Benzinga · January 3, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · September 27, 2024
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimatesbenzinga.com
Via Benzinga · August 6, 2024
Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?benzinga.com
Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate in patients with advanced solid tumors expressing Claudin 18.2. No Grade 4 or 5 adverse events were reported. The company plans further trial expansion in 2025.
Via Benzinga · August 6, 2024
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earningsbenzinga.com
Via Benzinga · August 6, 2024
Dow Jumps Over 300 Points; US Trade Gap Narrows In Junebenzinga.com
Via Benzinga · August 6, 2024
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testingbenzinga.com
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.
Via Benzinga · July 18, 2024
7 Top Stocks to Buy for Under $10: May 2024investorplace.com
By diversifying your portfolio with top stocks for under $10, you can profit from companies that are just starting their growth stories.
Via InvestorPlace · May 27, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · May 13, 2024
ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024investorplace.com
ELEV stock results show that Elevation Oncology missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 2, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · May 2, 2024
7 Top Stocks Under $7investorplace.com
Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now.
Via InvestorPlace · April 11, 2024
5 Healthcare Stocks to Buy for 2024investorplace.com
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via InvestorPlace · April 2, 2024
ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023investorplace.com
ELEV stock results show that Elevation Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024